2008Modern Medicine HealthRequires access

Clinical observation of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia

HE You-zuo

Open publisher page 0 citations

Abstract

Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.

About this research paper

What this paper is about

Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the curative effect of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia.Methods:120 patients with type 2 diabetes with hyperlipemia were randomly divided into three groups,namely simvastatin group,fenofibrate group and simvastatin and fenofibrate group;their results were observed respectively after administration.Results:After treatment,the serum levels of TC,LDL-C and TG in each group all decreased,while the serum level of HDL-C increased.The ranges of decreased level of serum TC,LDL-C and TG and increased level of serum HDL-C in simvastatin and fenofibrate group were all higher compared with those in two drugs used alone.Conclusion:The curative effect of simvastatin combined with fenofibrate in type 2 diabetes with hyperlipemia is satisfactory.

Key concepts: Fenofibrate, Simvastatin, Medicine, Internal medicine, Type 2 diabetes, Diabetes mellitus, Endocrinology, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of simvastatin and fenofibrate in the treatment of type 2 diabetes with hyperlipemia — Research Paper | ScholarLens